EUVIMEDEUVIMED entdecken
Crossref

Formulation Development And In Vitro Evaluation Of A Novel Drug Delivery System For Enhanced Therapeutic Performance

Dr. Ankur Singh, Dr. Niraj Lodha, Dr. Rakesh Venuturumilli, Madhumala. T., Dr. Khushboo Katharotiya, Dr. Swati S Mutha

International Journal of Drug Delivery Technology · 20.04.2026 · 16 (14s)

DOI: 10.25258/ijddt.16.14s.66 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 20.04.2026. Verfasst von Dr. Ankur Singh und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most therapeutically potential drugs do not perform optimally in clinical practices because of constraints related to traditional dosage formulations, such as low solubility, bioavailability, instability, and delivery to the sites. Novel drug delivery systems (NDDS) are now an effective approach to overcome such issues, as it allows controlled drug delivery, better pharmacokinetic characteristics and increased therapeutic accuracy. This review critically examines contemporary approaches to formulation development and in vitro evaluation of NDDS with an emphasis on their role in enhancing therapeutic performance. Key formulation design considerations, including drug physicochemical properties, excipient and carrier selection, and targeting or stimuli-responsive strategies, are discussed in relation to their impact on delivery efficiency and biological performance. Advances in fabrication technologies and systematic optimization approaches, particularly Quality by Design and statistical experimental designs, are highlighted as essential tools for achieving robust and reproducible formulations. The review further emphasizes the importance of comprehensive physicochemical and structural characterization in establishing stability, compatibility, and structure–performance relationships. In vitro drug release and biological performance assessment are examined as critical components for understanding delivery mechanisms and guiding formulation optimization, while acknowledging persistent challenges in achieving reliable in vitro–in vivo correlation. Regulatory, manufacturing, and scale-up matters are also taken into account to offer a translational view and extract future prospects of matching formulation innovation with clinical and industrial needs. This review highlights the importance of coordinated, foresighted, and outcome-based development measures to help the successful translation of the new system of drug delivery into effective therapies.

Zitieren

APA

Singh, D. A., Lodha, D. N., Venuturumilli, D. R., T., M., Katharotiya, D. K., & Mutha, D. S. S. (2026). Formulation Development And In Vitro Evaluation Of A Novel Drug Delivery System For Enhanced Therapeutic Performance. International Journal of Drug Delivery Technology, 16(14s). https://doi.org/10.25258/ijddt.16.14s.66

Vancouver

Singh DA, Lodha DN, Venuturumilli DR, T. M, Katharotiya DK, Mutha DSS. Formulation Development And In Vitro Evaluation Of A Novel Drug Delivery System For Enhanced Therapeutic Performance. International Journal of Drug Delivery Technology. 2026;16(14s). doi:10.25258/ijddt.16.14s.66

BibTeX
@article{Singh2026,
  author = {Singh, Dr. Ankur and Lodha, Dr. Niraj and Venuturumilli, Dr. Rakesh and T., Madhumala. and Katharotiya, Dr. Khushboo and Mutha, Dr. Swati S},
  title = {Formulation Development And In Vitro Evaluation Of A Novel Drug Delivery System For Enhanced Therapeutic Performance},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {14s},
  doi = {10.25258/ijddt.16.14s.66}
}
Kostenlos starten →